Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 54 for “"Riluzole"”.
-
Pharmacokinetics and Pharmacodynamics of Riluzole in Acute Spinal Cord Injury Patients
Riluzole, a benzothiazole sodium channel blocker that received FDA approval to attenuate neurodegeneration in amyotrophic lateral sclerosis (ALS) in 1995, was found to be safe and potentially efficacious in a spinal cord injury (SCI) population as evident in a Phase I clinical trial. The acute and …
-
Cost Effectiveness Analysis of Riluzole for ALS in Ontario Home Care Setting
… the factors associated with the prescription of riluzole and assess its cost-effectiveness for patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) in long stay home care in Ontario, Canada. Method: A retrospective cohort study was conducted using the Ontario Association of Community Care …
-
Improving Pharmacokinetics of Riluzole for Spinal Cord Injury: Formulation and Combination Therapy Approaches
… no pharmacological therapy available for SCI. Riluzole, an FDA approved drug for the treatment of amyotrophic lateral sclerosis (ALS), had demonstrated enhanced tissue sparing and recovery of motor function in a rodent SCI model. Following this, a phase I trial was conducted and safety of …
-
A comparison of riluzole and edaravone for the treatment of amyotrophic lateral sclerosis
… drugs for the treatment of ALS are riluzole and edaravone. Riluzole participates in glutamatergic transmission and has been previously shown to decrease excitotoxicity. Edaravone is a radical scavenger that decreases the generation of reactive oxygen species (ROS). In this thesis, …
-
Attenuation of Spatial Memory Impairment in a Tau Mouse Model of Alzheimer's Disease with Riluzole
… in TauP301L mice. To test this, we administered riluzole, an FDA-approved disease-modifying drug for the treatment of amyotrophic lateral sclerosis, which decreases glutamate release and increases glutamate uptake. TauP301L mice exhibited memory deficits in the 8-arm water radial arm maze (WRAM), …
-
GLUTAMATERGIC AND METABOLIC DYSREGULATION IN ALZHEIMER'S DISEASE MOUSE MODELS: THE IMPACT OF PRODROMAL RILUZOLE TREATMENT
… regulation in an amyloidogenic mouse model. Riluzole is a neuroprotective agent thought to restore hippocampal glutamatergic tone and improve spatial cognition in AD mice with prodromal administration. Previous studies have illustrated upregulation of glucose uptake and metabolism with …
-
Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation
… exists. Recently, several studies show that Riluzole has neuroprotective effect and promotes functional and neurological recoveries in animal models of brain and spinal cord ischemic and traumatic injuries; however, hepatotoxicity is a significant side effect concern for this therapy. …
-
Investigating the Role of Early Growth Response 1 (EGR1) Gene in Riluzole-Induced Apoptosis in Osteosarcoma
… treatments. Recent studies suggest that Riluzole, a drug approved for amyotrophic lateral sclerosis (ALS), may be repurposed for osteosarcoma treatment due to its ability to slow tumor progression and induce apoptosis. Previously, we have shown that Riluzole increases reactive oxygen …
-
Model-Informed Drug Development of Riluzole for Neuroprotection in Acute Spinal Cord Injury: Integrating Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes for Precision Medicine
… and a relatively small patient population. Riluzole, a sodium channel blocker with established neuroprotective properties, was evaluated in the Riluzole in Spinal Cord Injury Study (RISCIS), a Phase II/III clinical trial conducted by the North American Clinical Trials Network (NACTN). This …
-
A new pharmacological treatment for myocardial damage and arrhythmias arising from hypoxia, ischaemia or reperfusion
… studies were performed to determine whether Riluzole blocked persistent sodium currents and calcium influx during hypoxia and reperfusion. Isolated heart studies were performed to determine whether Riluzole provided cardioprotection during ischaemia-reperfusion. Whole animal studies were …
-
Riluzole as a Dual-Targeted Radiosensitizer for Osteosarcoma: Targeting Tumor Cells and Angiogenic Vasculature to Enhance Single High-Dose Radiotherapy Efficacy
… simultaneously. We therefore hypothesized that riluzole, an FDA-approved glutamate modulator that inhibits both the cystine/glutamate antiporter xCT (SLC7A11) and tumor angiogenesis sensitizes OS tumors to SDRT by concurrently targeting radioresistance mechanisms in both the tumor and vascular …
-
Investigation of Riluzole’s Synaptic Protection Mechanism Through HSF1-BDNF Axis
… amyotrophic lateral sclerosis (ALS) drug Riluzole has great potential in treating Alzheimer’s disease (AD) based on promising animal data as well as its known action on modulating synaptic transmission. However, its detailed mechanism of action is not fully understood. Here, we proposed …
-
Mechanistic Insights and Neuroprotective Approaches to Enhance Recovery in Cervical Spondylotic Myelopathy
… strategies are available to these patients. Riluzole, a sodium channel blocker, has been shown to be neuroprotective in models of acute spinal cord injury and to attenuate neural degeneration in clinical trials of amyotrophic lateral sclerosis. To test the efficacy of riluzole in experimental …
-
Novel Use of Dual Anti-Inflammatory Therapy to Overcome Drug Resistance and Improve Functional Recovery Following Spinal Cord Injury
… spinal cord uptake of systemically-delivered riluzole, a drug that is currently being evaluated in clinical trials as an SCI intervention. Blood-to-spinal cord riluzole penetration was reduced following SCI in wild-type but not Pgp-null rats, highlighting a critical role for Pgp in mediating …
-
Pharmacological modulation of Excitation - Inhibition balance in Autism Spectrum Disorders: a translational approach
… challenge with the E-I acting drug, riluzole. To first capture E-I dynamics at the intracellular level, I investigated riluzole-evoked changes in bulk tissue levels of E-I neurotransmitters in the medial prefrontal cortex (mPFC) and basal ganglia (BG)- regions known to be important in …
-
Amyotrophic Lateral Sclerosis: mechanism behind mutant SOD toxicity and improving current therapeutic strategies
… production of survival factors by glial cells. Riluzole is the only FDA approved drug for the treatment of ALS and it shows a small but significant increase in patient lifespan. Our results show that acute riluzole treatment stimulated trophic factor production by astrocytes and Schwann cells. …
-
A review of therapeutics targeting excitotoxicity in amyotrophic lateral sclerosis
… approved by the FDA for the treatment of ALS: riluzole and edaravone. Research is constantly being conducted to understand and develop further treatment modalities, however, many drugs have failed to demonstrate significant improvement in phase III trials. One of the pathophysiology that these …
-
Investigating excitation and inhibition balance in mouse models of autism spectrum disorder
… these core symptoms. N-acetylcysteine (NAC) and Riluzole are glutamate modulators that have been shown to have some positive effects in ASD patients. This thesis therefore investigated whether NAC and Riluzole could modulate any underlying E/I imbalances in the prefrontal cortex and dorsal …
-
Postnatal development of central rhythm generation of breathing in mammals
… from hypothermia-induced respiratory arrest, riluzole was used to block lNap in en bloc preparations from neonatal rats and hamsters. Riluzole of two concentrations was bath applied, both at constant temperature and after fictive respiratory arrest at very low temperatures. In neonatal rats, …
Page 1 of 3